(4aR,4bS,6aS,7S,7aS,8aS,8bS,8cR,8dR,9aR,9bR)-7,9b-dihydroxy-7-(3-hydroxypropyl)-4a,6a-dimethylhexadecahydro-1H-cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthren-2(3H)-one;(5R,6R,7R,8R,9S,10R,13S,14S,15S,16S,17S)-Octadecahydro-5,17-dihydroxy-17-(3-hydroxypropyl)-10,13-dimethyl-3H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthren-3-one; 17?-[3-Hydroxypropyl]-6?,7?:15?,16?-dimethylen-5?-androstan-5,17?-ol-3-one;
5-Beta-Hydroxy-Drospirenone-17-Propanol is a fully characterized chemical compound used as a reference standard of API Drospirenone. The standard offered is compliant with regulatory guidelines. 5-Beta-Hydroxy-Drospirenone-17-Propanol is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1357252-81-3
Related products
6ß,7ß,15ß,16ß-Dimethylene-3ß,5ß-dihydroxyandostan-17-one
M.F.
M.W. 330.47
CAT# AR-D02487
CAS# 82543-16-6
3β,5β-Dihydroxy-15β,16β-methylene-androst-6-en-17-one
M.F.
M.W. 316.44
CAT# AR-D02491
CAS# 82543-15-5
